Telix Accelerates Artificial Intelligence (AI) Development P

/PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the expansion of its artificial intelligence (AI) capability with...

Related Keywords

Japan , Belgium , Canada , Vienna , Wien , Austria , Australia , United States , Switzerland , Melbourne , Victoria , United Kingdom , Australian , Mark Europe , Thomas Beyer , Michael Wheatcroft , Dedicaid Gmbh , Head Of The Research Domain Quantitative Imaging , Prnewswire Telix Pharmaceuticals Limited , University Vienna , Telix Pharmaceuticals Limited Disclosure Committee , Drug Administration , Linkedin , Australian Therapeutic Goods Administration , Telix Pharmaceuticals , Health Canada , Australian Securities Exchange , Pharmaceuticals Limited , Vienna Based Dedicaid Gmbh , Medical University , Medical University Vienna , United States Food , Chief Scientist , Research Domain , Quantitative Imaging , Medical Physics , Listing Rule , Telix Pharmaceuticals Limited , Nucl Med ,